Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Pieris Pharma (PIRS)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 335,029
  • Shares Outstanding, K 44,790
  • Annual Sales, $ 5,830 K
  • Annual Income, $ -22,800 K
  • 36-Month Beta 1.79
  • Price/Sales 33.03
  • Price/Cash Flow N/A
  • Price/Book 72.26

Price Performance

See More
Period Period Low Period High Performance
1-Month
6.37 +16.64%
on 12/26/17
7.90 -5.95%
on 01/03/18
+1.06 (+16.64%)
since 12/22/17
3-Month
4.58 +62.23%
on 10/26/17
7.90 -5.95%
on 01/03/18
+2.31 (+45.12%)
since 10/23/17
52-Week
1.67 +344.91%
on 01/24/17
7.90 -5.95%
on 01/03/18
+5.73 (+337.06%)
since 01/23/17

Most Recent Stories

More News
Pieris Pharmaceuticals (PIRS) Soars: Stock Adds 15.2% in Session

Pieris Pharmaceuticals (PIRS) saw a big move last session, as its shares jumped more than 15% on the day, amid huge volumes.

PTGX : 19.47 (+2.91%)
PIRS : 7.43 (-0.67%)
4 Biotech Stocks That More Than Doubled This Year

We take a look at a few biotech stocks whose price has increased more than 100% in 2017.

CELG : 104.55 (+1.59%)
XOMA : 33.28 (-1.65%)
BLUE : 200.20 (+2.85%)
PBYI : 90.90 (-3.25%)
ALNY : 137.03 (+4.60%)
JUNO : 85.86 (-0.16%)
PIRS : 7.43 (-0.67%)
Loncar Cancer Immunotherapy Index Conducts Semi-Annual Rebalance

Loncar Investments, LLC today announced the result of the semi-annual rebalance and reconstitution of the Loncar Cancer Immunotherapy Index, a stock index of the top 30 companies developing...

ADXS : 3.06 (+1.66%)
CNCR : 28.70 (+2.57%)
CRIS : 0.75 (+8.45%)
IDRA : 2.16 (-0.46%)
SNDX : 10.49 (-3.05%)
NKTR : 77.79 (+1.32%)
PIRS : 7.43 (-0.67%)
The Zacks Analyst Blog Highlights: Halozyme Therapeutics, Protagonist Therapeutics, Aptose Biosciences and Pieris Pharmaceuticals

The Zacks Analyst Blog Highlights: Halozyme Therapeutics, Protagonist Therapeutics, Aptose Biosciences and Pieris Pharmaceuticals

PTGX : 19.47 (+2.91%)
APTO : 3.43 (+3.31%)
HALO : 19.68 (+3.85%)
PIRS : 7.43 (-0.67%)
4 Top-Ranked Biotech Stocks Under $20 With Room for Growth

We take a look at the biotech stocks with a potential for growth keeping in mind that the industry has witnessed a rebound in 2017 from last year's challenges.

PTGX : 19.47 (+2.91%)
APTO : 3.43 (+3.31%)
HALO : 19.68 (+3.85%)
PIRS : 7.43 (-0.67%)
Pieris Pharmaceuticals Announces Ethics and Regulatory Clearance to Begin Clinical Testing of Inhaled Respiratory Program, PRS-060/AZD1402

BOSTON, MA--(Marketwired - December 07, 2017) - Pieris Pharmaceuticals, Inc. (NASDAQ: PIRS), a clinical-stage biotechnology company advancing novel biotherapeutics through its proprietary Anticalin®...

PIRS : 7.43 (-0.67%)
Pieris Pharmaceuticals Appoints James Geraghty as Chairman of the Board of Directors

BOSTON, MA--(Marketwired - November 21, 2017) - Pieris Pharmaceuticals, Inc. (NASDAQ: PIRS), a clinical-stage biotechnology company advancing novel biotherapeutics through its proprietary Anticalin® technology...

PIRS : 7.43 (-0.67%)
Pieris Pharmaceuticals, Inc. to Host Earnings Call

NEW YORK, NY / ACCESSWIRE / November 9, 2017 / Pieris Pharmaceuticals, Inc. (NASDAQ: PIRS) will be discussing their earnings results in their Q3 Earnings Call to be held on November 9, 2017 at 10:00 AM...

PIRS : 7.43 (-0.67%)
Pieris Pharmaceuticals Reports Financial Results for the Third Quarter Ended September 30, 2017, and Provides Corporate Update

BOSTON, MA--(Marketwired - November 08, 2017) - Pieris Pharmaceuticals, Inc. (NASDAQ: PIRS), a clinical-stage biotechnology company advancing novel biotherapeutics through its proprietary Anticalin® technology...

PIRS : 7.43 (-0.67%)
Pieris Pharmaceuticals Reports Financial Results for the Third Quarter Ended September 30, 2017, and Provides Corporate Update

BOSTON, MA--(Marketwired - November 08, 2017) - Pieris Pharmaceuticals, Inc. (NASDAQ: PIRS), a clinical-stage biotechnology company advancing novel biotherapeutics through its proprietary Anticalin® technology...

PIRS : 7.43 (-0.67%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 64% Buy with a Average short term outlook on maintaining the current direction.

Longer term, the trend strength is Strong. Long term indicators fully support a continuation of the trend.

See More

Business Summary

Pieris Pharmaceuticals, Inc. is a biopharmaceutical company. The Company's drug technology consists of Anticalin(R) to treat cancer, severe asthma, anemia and other medical conditions. Pieris Pharmaceuticals, Inc. is based in Freising-Weihenstephan, Germany.

See More

Key Turning Points

2nd Resistance Point 7.95
1st Resistance Point 7.69
Last Price 7.43
1st Support Level 7.28
2nd Support Level 7.13

See More

52-Week High 7.90
Last Price 7.43
Fibonacci 61.8% 5.52
Fibonacci 50% 4.78
Fibonacci 38.2% 4.05
52-Week Low 1.67

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
New Chart Menu
Right-click anywhere on the chart to open the Interactive Chart menu.